Healthcare Decisions Post-Testing, Risk-reducing and Preventative Strategies Using LYNCH Genetic Testing Reducing, and Preventative Strategies Using LYNCH Genetic Testing



Status:Enrolling by invitation
Conditions:Colorectal Cancer, Cervical Cancer, Cancer, Cancer, Endometrial Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 64
Updated:1/25/2019
Start Date:October 17, 2017
End Date:November 1, 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Medical Provider Experience Assessment Healthcare Decisions Post-Testing, Risk-Reducing, and Preventative Strategies Using LYNCH Genetic Testing

Increase surveillance for LYNCH Syndrome

The purpose of this minimal risk, observational survey is to increase surveillance for Lynch
Syndrome (hereditary non-polyposis colon cancer), Colorectal, and Endometrial cancer, also to
determine targeted risk-reducing and preventative strategies.

Inclusion Criteria:

- Must be a Medical Practitioner

- Medical Doctor (MD)

- Doctor of Osteopathic (DO)

- Physician Assistant (PA)

- Advanced Practice Registered Nurse (APRN)

- Nurse Practitioner (NP)

- Must have a current standard operating procedure that includes obtaining/reviewing
medical history and family medical history.

Exclusion Criteria:

- Government-funded insurance data cannot be included in the study.
We found this trial at
1
site
DCABM
21147 Leonard Road
Land O' Lakes, Florida 33558
?
mi
from
Land O' Lakes, FL
Click here to add this to my saved trials